BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 22248828)

  • 1. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
    Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
    J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases.
    Lee WI; Huang JL; Wu TS; Lee MH; Chen IJ; Yu KH; Liu CY; Yang CH; Hsieh MY; Lin YL; Shih YF; Jaing TH; Huang SC; Kuo TT; Ku CL
    Immunobiology; 2013 May; 218(5):762-71. PubMed ID: 23083630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
    Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
    Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese patients with defective IL-12/23-interferon-gamma circuit in Taiwan: partial dominant interferon-gamma receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor beta1 mutation as pneumatocele.
    Lee WI; Huang JL; Lin TY; Hsueh C; Wong AM; Hsieh MY; Chiu CH; Jaing TH
    J Clin Immunol; 2009 Mar; 29(2):238-45. PubMed ID: 18972195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.
    van Coller A; Glanzmann B; Cornelissen H; Möller M; Kinnear C; Esser M; Glashoff R
    BMC Immunol; 2021 Sep; 22(1):62. PubMed ID: 34517836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases.
    Bustamante J; Picard C; Boisson-Dupuis S; Abel L; Casanova JL
    Ann N Y Acad Sci; 2011 Dec; 1246():92-101. PubMed ID: 22236433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.
    Bustamante J; Boisson-Dupuis S; Abel L; Casanova JL
    Semin Immunol; 2014 Dec; 26(6):454-70. PubMed ID: 25453225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of susceptibility to Mycobacterial infections: IRF8, a new kid on the block.
    Salem S; Gros P
    Adv Exp Med Biol; 2013; 783():45-80. PubMed ID: 23468103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.
    Lee PP
    Ann Acad Med Singap; 2015 Aug; 44(8):297-301. PubMed ID: 26477962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity.
    Dolezalova K; Strachan T; Matej R; Ricna D; Bloomfield M
    Eur J Dermatol; 2022 Sep; 32(4):495-504. PubMed ID: 36069176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
    Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
    J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the Link Between Ectodermal Disorders and Primary Immunodeficiencies.
    D'Assante R; Fusco A; Palamaro L; Giardino G; Gallo V; Cirillo E; Pignata C
    Int Rev Immunol; 2016; 35(1):25-38. PubMed ID: 25774666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M
    J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reccurent mycobacterial diseases in patients with impaired axis IL-12/INF-gamma].
    Strach M; Nalepa P; Sulicka-Grodzicka J; Kierzkowska I; Siedlar M; Grodzicki T
    Przegl Lek; 2013; 70(12):1058-60. PubMed ID: 24720128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India.
    Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM
    Front Immunol; 2021; 12():631298. PubMed ID: 33732252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases.
    Al-Muhsen S; Casanova JL
    J Allergy Clin Immunol; 2008 Dec; 122(6):1043-51; quiz 1052-3. PubMed ID: 19084105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial infections in primary immunodeficiency patients.
    Galkina E; Kondratenko I; Bologov A
    Adv Exp Med Biol; 2007; 601():75-81. PubMed ID: 17712994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity.
    Holland SM
    Immunol Res; 2007; 38(1-3):342-6. PubMed ID: 17917041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
    Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J
    Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases.
    Wang LH; Yen CL; Chang TC; Liu CC; Shieh CC
    J Microbiol Immunol Infect; 2012 Dec; 45(6):411-7. PubMed ID: 23036270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.